Identification and characterization of mefloquine efficacy against JC virus in vitro.
about
Human polyomavirus reactivation: disease pathogenesis and treatment approachesCMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytesMolecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainProgressive multifocal leukoencephalopathy: current treatment options and future perspectivesProgressive multifocal leukoencephalopathy: clinical and molecular aspectsIn Vitro and In Vivo Models for the Study of Human Polyomavirus InfectionProgressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarateProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Clinical Trials in Neurovirology: Successes, Challenges, and PitfallsSuppressive effect of PARP-1 inhibitor on JC virus replication in vitro.Progressive multifocal leukoencephalopathy as the first manifestation of occult sarcoidosis: case report and review of the literatureProgressive multifocal leukoencephalopathy in HIV-1 infection.Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis.Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures.Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugsPlasmodium drug targets outside the genetic control of the parasite.Progressive multifocal leukoencephalopathy in a patient without immunodeficiencyAn animal model for progressive multifocal leukoencephalopathyProgressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MSPathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.Metabolic profile of PML lesions in patients with and without IRIS: an observational studyComplex Membrane Channel Blockade: A Unifying Hypothesis for the Prodromal and Acute Neuropsychiatric Sequelae Resulting from Exposure to the Antimalarial Drug Mefloquine.Progressive Multifocal Leukoencephalopathy with Negative JC Virus PCR following Treatment of Follicular Lymphoma: Implications for Biologics in the Era of Targeted Cancer Therapy.Complications of immunosuppressive/immunomodulatory therapy in neurological diseases.A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomesTherapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.Progressive multifocal leukoencephalopathy in an immunocompetent patient?Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy.Progressive multifocal leukoencephalopathy in a 62-year-old immunocompetent woman.Treating multiple sclerosis with monoclonal antibodies: a 2010 update.Progressive multifocal leukoencephalopathy: what's new?Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?Monoclonal antibody therapy in multiple sclerosis: Paradigm shifts and emerging challenges.Managing MS in a changing treatment landscape.Progressive multifocal leukoencephalopathy and natalizumab.
P2860
Q21285083-C9D18829-CC18-44F5-953A-4086D7289491Q24599841-FB7759BC-B221-4030-B644-74E8B9C088D7Q24619923-FC244581-E974-4620-9150-BE705D46E8E4Q26776236-65D312D7-3F55-4A1C-862E-ACC8AA066871Q26858968-A67457DF-E23C-4AC3-90E2-009CBE3B218FQ28074684-46928BA6-8D31-4E93-BD1D-5FBEEB3563FBQ28083338-706662A9-A3A8-4E7B-B5B0-65C56AE9C6B1Q30235523-7A07716E-AB7D-4DCC-AF97-E7E11F7B8606Q30245002-B73E4255-295E-4453-99A2-55DB7DFD21A7Q30250271-D0E23FA3-A02C-4045-94AE-7B4F8DDC1660Q30422440-6E4F0D5F-E9AE-4C79-A0C6-FD45E86CB074Q30583302-43DBB7EE-1F27-4903-94F4-B432FF931A40Q33506561-80AB481C-6907-43E8-AF1B-2B9651BD144AQ33573208-EA85F2B2-D35F-4ED2-B99E-B51AB266EB17Q33605681-BCAC3FC5-DE02-4FD1-B64E-44BCD19FC47BQ33893285-0059DF40-747B-4EC8-8EF1-E6987D93C4A9Q34110804-37DA3FF2-0C17-4C79-9E8D-85557F421A16Q34290158-054AAA2B-2EE0-4519-B661-0FB970FC3B6EQ34647087-86FC81F4-747C-44A3-8861-18B841E5896EQ34678568-8929B209-13F9-4223-8672-9C65D547E110Q35104446-B8A09033-A5C9-43EB-86DC-F148D73F8102Q35145409-FE104D6C-55E9-4D13-85C6-BB40BE9BAE9AQ35476415-9FD91173-9035-44A8-806B-203FB19C8E81Q35656939-59093FDE-0F4C-47AE-9D20-B2EB8971B3C8Q36198630-2DB9A8DA-C6AC-4942-A54B-B098448FA671Q36241478-B98977D0-EE4C-4DD8-B33D-DEAA1F9DFE0BQ36409053-643F848B-F1CD-4C05-81FF-6FDA2694CE4BQ37013065-FB132F13-8EB8-47FA-9344-BB053F816905Q37135539-A62734B6-FC33-4435-AC18-7DB37694DC61Q37180338-737A75F2-36D0-4283-A0B1-F2C1BE34B17DQ37206687-A5C1AF0D-D5FD-44C9-9F98-7D71093426F5Q37251352-D29C40A5-C7E5-4C3D-8EA1-EC5253BD2500Q37455953-0026ED9F-CE74-4CE9-AF38-FFA3E8F62949Q37663449-403336DB-379A-4C41-84CF-8A538D7AC168Q37737305-43376C5A-4337-4A98-BEF9-63860EBFDF5FQ37755922-F6A70B72-0211-47A2-882A-527F6A6E2A49Q37778944-BDCE7447-3A4C-4E81-A0FE-BB0B7619971BQ37814815-E65EA2B5-3720-41A6-8BFD-305C950221C8Q37857752-F0485095-5CC4-4359-A58A-18D39B01C603Q37885823-22F9EFC0-A713-42C4-9D12-C27EEDEE298E
P2860
Identification and characterization of mefloquine efficacy against JC virus in vitro.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Identification and characterization of mefloquine efficacy against JC virus in vitro.
@en
Identification and characterization of mefloquine efficacy against JC virus in vitro.
@nl
type
label
Identification and characterization of mefloquine efficacy against JC virus in vitro.
@en
Identification and characterization of mefloquine efficacy against JC virus in vitro.
@nl
prefLabel
Identification and characterization of mefloquine efficacy against JC virus in vitro.
@en
Identification and characterization of mefloquine efficacy against JC virus in vitro.
@nl
P2093
P2860
P356
P1476
Identification and characterization of mefloquine efficacy against JC virus in vitro.
@en
P2093
Alexey Lugovskoy
Kenneth Simon
Leonid Gorelik
Margot Brickelmaier
Marta M Reviriego-Mendoza
Norm Allaire
Ramya Kartikeyan
Richard J Frisque
P2860
P304
P356
10.1128/AAC.01614-08
P407
P577
2009-03-02T00:00:00Z